JPRN-UMIN000002015已完成3 期
Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung - Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Symptomatic brain metastasis or brain metastasis which needs treatment like adrenal corticosteroids or antiepileptic drugs. 2)Other current active malignancy. 3)Superior vena cava syndrome. 4)Malignant pericardial/ pleural/ peritoneal effusion which need continuous drainage or rapidly increase after temporary drainage. 5)Patient has received radiotherapy to the primary lesion. 6)Patient received palliative radiotherapy except to the primary lesion in last 2 weeks. 7)Patient has a clinically significant con current illness. 8)Interstitial pneumonia or pulmonary fibrosis documented obviously in chest X ray. 9)Pregnant or breast-feeding woman or patient who doesn't agree to contraception. 10)Patient has a history of severe allergy or hypersensitivity. 11)Any other reason that, in the opinion of the investigator, precludes the subject from participating in the study.
研究者
相似试验
已完成
1 期
Phase 1/2 study of the combination of nedaplatin and ifosfamide in patients with advanced or recurrent cervical cancerAdvanced or recurrent cervical cancerJPRN-UMIN000000464Graduate School of Medicine, Chiba University25
已完成
1 期
A phase I trial of weekly Nedaplatin and concurrent thoracic radiotherapy for elderly patients with locally advanced squamous cell lung cancerJPRN-UMIN000021226Osaka medical college hospital18
招募中
1 期
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer (POD1UM-304)CTIS2022-501987-16-00Incyte Corp.576
进行中（未招募）
1 期
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer (POD1UM-304)Male and female participants at least 18 years of age (or as per adult age applicable per local country requirements) who have metastatic nonsquamous or squamous NSCLC.MedDRA version: 20.1Level: LLTClassification code 10080083Term: Advanced lung cancerSystem Organ Class: 100000004864EUCTR2019-003372-39-BGIncyte Corporation600
进行中（未招募）
1 期
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer (POD1UM-304)Male and female participants at least 18 years of age (or as per adult age applicable per local country requirements) who have metastatic nonsquamous or squamous NSCLC.MedDRA version: 20.1Level: LLTClassification code 10080083Term: Advanced lung cancerSystem Organ Class: 100000004864EUCTR2019-003372-39-HUIncyte Corporation530